The Operational Reality of Reshoring Pharma Manufacturing: Q&A with Rohit Tripathi

Why It Matters

For industry operators, the topic points to the practical challenges of moving pharma production closer to domestic markets rather than treating reshoring as a simple strategic slogan. Investors and supply-chain leaders would read this through questions of capacity, compliance burden, labor availability, and capital requirements.